EMPOWERING VISIONARIES
Venture Capital that invests exclusively
in the Life Science industry
ABOUT US
Solas BioVentures is an early-stage investor in biopharmaceuticals, medical devices, and digital health. Our home is Chattanooga, Tennessee. Our reach is worldwide
EXPERIENCE
Spanning medicine, biotechnology, operations, and finance, our Investment Team combines decades of hands-on expertise with a proven record investing in the medtech space
PARTNERS
Our Investment Team is strengthened by a network of Limited Partners who contribute domain expertise when evaluating opportunities in their respective fields
OUR PHILOSOPHY
We maintain a founder-centric approach to enable breakthrough medicine and meaningful technological innovation. Our team and portfolio founders are visionaries, contrarians, entrepreneurs, doctors, scientists, lawyers, and financiers united by the belief that their work can — and must — transform the standard of care and patient outcomes
At the Intersection of Medicine, Science, and Finance
DAVID ADAIR, MD, MBA
Co-Founder & Managing Director
MARK HACKETT, JD
Co-Founder & Partner
DAVID BELITZ
Partner
MICHAEL HOEY, PhD, MBA
Partner
MICHAEL ACKERMANN, PHD
Partner
LANA CARON
Partner
TRAVIS MANASCO, MD
Partner
JOSHUA ECKELBERRY, MBA
Partner
JULIA RAY, BS
Controller
.jpeg)
EMMA HECKENBERG, PhD
Analyst
DISCLOSURE
Solas BioVentures Management, LLC (“Solas”) is an SEC registered investment adviser. Solas’s website is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of Solas’s website on the Internet should not be construed by anyone as Solas’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet. For information pertaining to the registration status of Solas and its Form ADV, please see here. Past performance is not necessarily indicative of future results, and all investment is subject to loss. Please carefully review the disclosure documents for Solas’s associated investment programs for a full description of all risk associated with investment.